The first drug to treat the symptoms of Rett syndrome was recently approved, following a Nature Medicine study publishing results from the pivotal phase 3 LAVENDER study led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety of trofinetide.

Vanderbilt research finds that the U.S. government could save taxpayers between $228 million-$2.15 billion a year if insurers who operate its Medicare Part D plans purchased seven generic oncology drugs at the same prices obtained by the Mark Cuban Cost Plus Drug Company.

Vanderbilt University Medical Center is piloting several new physical security measures, including metal detectors.

Vanderbilt University Medical Center (VUMC) is piloting several new physical security measures, including metal detectors, starting in May.

Vanderbilt research shows a common anesthesia drug could be beneficial in reducing pressure inside the skull of children with traumatic brain injuries.

A Vanderbilt study found the number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly increased since 2010, rising from 16% to 60% for low-risk patients and from 8% to 22% for patients with favorable intermediate-risk cancers.